Picard / SynCardia Featured on the Cruxx of MedTech Podcast

5 days ago

TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company…

Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform

5 days ago

MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of…

ClinNEXUS Appoints Jovan Hollins to Chief Operating Officer

5 days ago

- A seasoned healthcare executive with nearly two decades of leadership experience, Mr. Jovan Hollins will lead ClinNEXUS’ operations at…

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

5 days ago

KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first…

Dror Secures Israeli Regulatory Approval to Market and Sell Its Next Generation Smile Correction Solution

5 days ago

AMAR regulatory approval will allow the Company to launch ZSmile in Israel in 2026 as a precursor to a larger…

Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal

5 days ago

Nu-Tek Manufacturing Facility Nu-Tek's state-of-the-art facility, purpose built to provide over 2000 metric tons of animal-free production annually. Nu-Tek BioSciences…

Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects 

5 days ago

– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising…

Propanc Biopharma Provides Shareholder Update

5 days ago

CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma,…

Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet

5 days ago

Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation,…

SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025

5 days ago

Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 13, 2026…